Supernus Pharmaceuticals | SUPN - Operating Profit


Supernus Pharmaceuticals reported $13.82M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025